HIF-independent role of Prolyl Hydroxylases in the cellular response to amino acids by Duran, R.V. et al.
ORIGINAL ARTICLE
HIF-independent role of prolyl hydroxylases in the cellular
response to amino acids
RV Dura´n1,2, ED MacKenzie1, H Boulahbel1, C Frezza1, L Heiserich1, S Tardito1,3, O Bussolati3, S Rocha4, MN Hall2 and E Gottlieb1
Hypoxia-inducible factor (HIF) prolyl hydroxylases (PHDs) are a-ketoglutarate (aKG)-dependent dioxygenases that function as
cellular oxygen sensors. However, PHD activity also depends on factors other than oxygen, especially aKG, a key metabolic
compound closely linked to amino-acid metabolism. We examined the connection between amino-acid availability and PHD
activity. We found that amino-acid starvation leads to aKG depletion and to PHD inactivation but not to HIF stabilization.
Furthermore, pharmacologic or genetic inhibition of PHDs induced autophagy and prevented mammalian target of rapamycin
complex 1 (mTORC1) activation by amino acids in a HIF-independent manner. Therefore, PHDs sense not only oxygen but also
respond to amino acids, constituting a broad intracellular nutrient-sensing network.
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INTRODUCTION
Prolyl hydroxylases (PHDs) are considered the oxygen sensors of
cells. The cellular response to hypoxia is mediated by the
transcription factor hypoxia-inducible factor (HIF)1, constituted
by HIF1a and HIF1b. In the presence of molecular oxygen, PHD
proteins hydroxylate HIF1a in its oxygen-dependent degradation
(ODD) domain allowing for the proteasomal degradation of
HIF1a.1–3 During hypoxia, the lack of molecular oxygen leads to
the inhibition of PHDs, the consequent stabilization of HIF1 and
the expression of its target genes.4 In humans, the PHD family
comprises three different a-ketoglutarate (aKG)-dependent
dioxygenases (PHD1, PHD2 and PHD3), requiring iron and
ascorbate as cofactors. For the hydroxylation process, oxygen
atoms are obtained from molecular oxygen while aKG provides
electrons while being decarboxylated to succinate. First
discovered in Caenorhabditis elegans, PHDs were later found in
many other organisms including mammals, Drosophila,
Dictyostelium, ﬁssion yeast and even photosynthetic organisms
such as Chlamydomonas reinhardtii.5–9 The presence of PHD
proteins in organisms lacking HIF raises the possibility PHD
functions beyond HIF regulation.
It was previously discovered that PHDs are inhibited by their
product, succinate, and that mutations in the tumor suppressor
succinate dehydrogenase lead to the accumulation of succinate
and consequently to HIF1 induction due to the inactivation of
PHDs.10,11 This effect is reversed by artiﬁcially increasing
intracellular aKG levels.12 This ﬁnding pointed to the importance
of aKG availability for PHD activity.
aKG is a central metabolic hub, involved in several crucial
pathways. It participates in the tricarboxylic acid (TCA) cycle and in
amino-acid transamination. Furthermore, aKG is the product of
glutamine deamination (glutaminolysis), an anaplerotic process,
which replenishes the TCA cycle. During glutaminolysis, glutamine
is deaminated to aKG in a two steps process catalyzed by
glutaminase and glutamate dehydrogenase, the latter is positively
regulated by leucine.13 The degradation of other amino acids,
such as arginine, histidine or proline, also leads to the production
of aKG. Thus, aKG is closely connected to amino-acid metabolism.
Indeed, glutamine deprivation causes a marked drop in the levels
of different TCA cycle intermediates.14 As PHDs are strictly
dependent on aKG as an electron donor for prolyl
hydroxylation, we hypothesized that PHDs may be dependent
on amino-acid availability. Acting as aKG sensors, PHDs would
thus provide not only oxygen-monitoring activity, but a broader
metabolic-sensing system that also monitors the TCA cycle status.
To date, it is not well understood how cells sense amino-acid
availability, although it is known that, the serine/threonine kinase
mammalian target of rapamycin complex 1 (mTORC1) is activated
by amino acids.15
In this work, we demonstrated that both intracellular aKG levels
and PHD activity are strictly dependent on amino-acid availability.
We also demonstrated that PHD activity is required for mTORC1
activation by amino acids. We therefore linked amino-acid
availability and mTORC1 activity via aKG production and PHD
activation.
RESULTS
Amino-acid starvation causes depletion of aKG that leads to PHD
inactivation
Using the U2OS cell line, we ﬁrst determined the intracellular aKG
levels and PHD activity in response to amino-acid availability.
Amino-acid starvation caused a marked decrease in the intracel-
lular levels of aKG (Figure 1a). Interestingly, glucose deprivation
did not cause a comparable decrease in aKG (Figure 1a),
supporting the notion that amino acids and not glucose are
essential for maintaining TCA cycle components by sustaining the
levels of aKG.
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As aKG is a co-substrate of PHDs, we next investigated whether
amino-acid availability is required for PHD activity. Intracellular
PHD activity was monitored using the HCT116 cell line that stably
expresses a green ﬂuorescent protein (GFP)–ODD fusion protein,12
the levels of which inversely correlate with PHD activity. In the
presence of amino acids, GFP-ODD levels were low, conﬁrming
high PHD activity under normal nutritional conditions (Figure 1b, i).
After inhibition of PHDs using dimethyloxallyl glycine (DMOG) GFP-
ODD levels accumulated (Figure 1b, ii). In accordance with the
observed changes in aKG levels (Figure 1a), GFP accumulated only
after amino acid but not glucose starvation (Figure 1b, iii–iv) in a
dose-dependent manner (Supplementary Figures S1A, B). We
therefore concluded that PHD inactivation correlates with aKG
reduction during amino-acid starvation.
As amino acids control intracellular aKG levels, we investigated
whether PHD inactivation observed after amino-acid withdrawal is
a direct consequence of the drop in aKG. For this purpose, the
1-triﬂuoromethylbenzyl-aKG ester (TaKG), a cell permeable ester
of aKG,12 was utilized. The addition of TaKG to U2OS cells
replenished aKG levels during amino-acid deprivation (Figure 1c)
and restored low GFP-ODD levels (Figures 1d, e). This effect of
TaKG was independent of mTORC1 activity, as rapamycin did not
alter the GFP-ODD degradation upon TaKG addition (Figure 1e).
Similar results were obtained in U2OS cells transiently expressing
GFP-ODD (Supplementary Figure S1C). These results conﬁrmed
that reduction of PHD activity after amino-acid withdrawal is
indeed caused by the loss of aKG.
Amino-acid starvation may have an impact on mitochondrial
functions causing changes in the energetic status of cells. Such a
bioenergetic stress could signal to PHDs. Indeed, amino-acid-
starved cells demonstrated reduced mitochondrial-dependent
respiration and ATP levels, however, the addition of aKG to the
amino-acid-starved cells did not rescue cells from this bioener-
getic deﬁcit (Supplementary Figure S2). Furthermore, unlike
glucose, amino-acid starvation did not increase the phosphoryla-
tion status of AMP-activated protein kinase (AMPK) (Figure 1f), an
energy-sensor enzyme, which is phosphorylated during bioener-
getic failure.16 These results further conﬁrmed that the
inactivation of PHDs following amino-acid starvation was not
mediated by the bioenergetic status of the cell.
Loss of PHD activity during amino-acid starvation does not
activate HIF
The best characterized PHD targets are the HIFa proteins, which
accumulates under hypoxia. Therefore, we studied whether
inactivation of PHDs during amino-acid deprivation leads to the
accumulation of HIFa and to an increase in HIF transcriptional
Figure 1. Amino-acid starvation decreases aKG levels and inhibit PHD activity. (a) Intracellular aKG levels of U2OS cells after incubation for 3 h
under the indicated condition. (b) GFP-ODD accumulation in HCT116 under the indicated condition. (c) Intracellular aKG content of starved
cells treated with TaKG as indicated. Non-starved cells were used as control. (d, e) GFP-ODD accumulation examined microscopically (d) or by
western blot (e) in fed and starved cells treated with TaKG and rapamycin (RAP) as indicated. (f ) Phosphorylation levels of AMPK in U2OS cells
incubated in either the presence or absence of amino acids and glucose. Results represent the average and s.d. of three independent
experiments (*Po0.05).
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activity. Despite the inactivation of PHDs (Figures 1a–e), no
accumulation of HIF1a was observed under amino-acid starvation
(Figure 2a). Analysis of various HIF target genes (REDD1, GLUT1
and BNIP3) as well as of HIF transcriptional activity (using a
luciferase reporter) did not reveal changes in HIF activity (Figures 2
a, b). This suggests that despite the fact that PHDs are inhibited
after amino-acid starvation, HIF does not accumulate, likely due to
a decrease in protein translation.17 Indeed, the inhibition of the
proteasome using MG132 did not induce HIF1a accumulation
during amino-acid starvation (Supplementary Figure S3A).
In support of this notion, HIF1a and REDD1 levels were not
increased by DMOG or hypoxia when cells were starved for amino
acids (Figures 2c, d). The transcription factor nuclear factor (NF)-kB
is an additional target of PHDs.18 However, amino-acid withdrawal
did not cause any change in NF-kB signaling (Figures 2e, f).
Therefore, we concluded that neither HIF nor NF-kB is activated
upon PHD inhibition in response to amino-acid starvation.
PHD inhibition induces autophagy independently of HIF
The role of PHDs in the biological response to nutrients
deprivation was next analyzed. As amino-acid starvation is known
to induce autophagy,19 and the activity of PHDs is inhibited in the
absence of amino acid, a relation between PHD inhibition and
autophagy was investigated, using the aggregation of the LC3–
GFP fusion protein in autophagosomes as a reporter. Indeed,
inhibition of PHDs by DMOG for 5 h in U2OS cells was sufﬁcient to
markedly induce autophagy to a similar extent as amino-acid
starvation (Figures 3a, b and Supplementary Figures S3B, C). As we
did not observe HIF accumulation after PHD inhibition during
amino-acid starvation, it is unlikely that the corresponding
autophagy mediated by PHD inhibition is HIF dependent. Indeed,
efﬁcient silencing of HIF activity (Supplementary Figure S4) did not
reduce the ability of the PHD inhibitor DMOG to induce
autophagy (Figures 3a, b).
Reduction of intracellular aKG levels during amino-acid starvation
correlates with mTORC1 inhibition
The data presented so far position the aKG-dependent
activity of PHDs as a sensor of amino acids. Therefore, we
next investigated whether the reduction in intracellular levels of
aKG correlates with the well-characterized inhibition of mTORC1
during amino-acid starvation. As shown in Figures 4a, b, the
Figure 2. Inactivation of PHDs during amino-acid starvation does not activate HIF. (a) Protein levels of HIF1a, REDD1, Glut1 and BNIP3 in U2OS
cells incubated in the presence or absence of amino acids for the indicated time. A positive control of cells incubated under hypoxic
conditions for 12 h (Hyp) was included. (b) U2OS cells expressing a construct containing either a wild-type HRE-luciferase reporter (black bars)
or a mutant HRE-luciferase reporter unable to respond to HIF1a (white bars) were incubated in the presence or absence of amino acids for the
indicated time and the luciferase intensity was analyzed using a luminometer (values represent average and s.e. of three independent
experiments). A positive control of cells incubated in hypoxic conditions for 12 h was included (U¼untransfected). (c) Protein levels of HIF1a
and REDD1 in U2OS cells incubated in fed or starving conditions for 2 h followed by 30min of incubation in the presence or absence of
DMOG. (d) U2OS cells where incubated in hypoxia (1% O2) in starving conditions for 2 h followed by 1 extra hour of incubation in the
presence or absence of amino acids. HIF1a accumulation and S6 phosphorylation were then analyzed by western blot. (e, f ) U2OS cells stably
expressing NF-kB-reporter construct pGL4.32[luc2P/NF-kB-RE/Hygro] were incubated for the indicated time in KRBB either in the presence or
absence of all amino acids or tumor necrosis factor-a (10 ng/ml). Activation of NF-kB was analyzed by luminescence analysis of the NF-kB-
luciferase reporter (e) and by phosphorylation of IkB kinase (IKK) and IKb-a by western blot (f ). Graph depicts mean and s.d. of three
independent experiments and represents fold activation compared with untreated samples.
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kinetics of the reduction of intracellular aKG levels upon amino-
acid withdrawal correlates with the inhibition of mTORC1
(measured by the phosphorylation status of its target proteins
S6K and S6). Furthermore, re-addition of amino acids to amino-
acid-starved cells restored both aKG levels and mTORC1 activity
(Figures 4c, d). As leucine is a key amino acid in the regulation of
mTORC1,20 we also investigated the reduction of aKG levels after
leucine starvation only. Similar to our observations with complete
amino-acid starvation, leucine deprivation resulted in a reduction
in aKG that correlated with mTORC1 inhibition (Supplementary
Figures S5A, B). This result positioned leucine as a critical amino
acid for sustaining aKG production. In support of this, the
inhibition of aKG production by 6-diazo-5-oxo-l-norleucine, a
glutaminase inhibitor, which blocks aKG production from
glutamine, also impaired the activation of mTORC1 by leucine
and glutamine (Supplementary Figure S5C). Furthermore, starving
U2OS cells of glutamine reduced the intracellular levels glutamate
and glutamine, but it had no effect on the levels of intracellular
leucine or any other amino acid (Supplementary Figure S6).
Therefore, at least in U2OS cells, glutamine is required to sustain
the intracellular levels of aKG, but not of leucine, contrary to a
previous report.21
Inhibition of PHDs blocks the response of mTORC1 to amino acids
We next studied whether PHD activity is required for mTORC1
activation by amino acids. Inhibition of PHDs by DMOG blocked
the ability of amino acids to re-activate mTORC1, as demonstrated
by the lack of phosphorylation of the mTORC1 target proteins S6K,
S6 and 4EBP1 (Figures 5a, b). Similar results were obtained using
cobalt chloride (Figure 5b), a different inhibitor for PHDs.
To further substantiate these results, PHDs were silenced with
three different shRNAs, efﬁciently targeting each of the PHDs
(Supplementary Figure S7). Although individual silencing of each
of the PHDs did not block mTORC1 activation by amino acids
(Supplementary Figures S8A–C), the silencing of all three PHDs
simultaneously caused a marked inhibition in ribosomal S6 and
S6K phosphorylation in response to amino acids (Figures 5c, d).
Therefore, the results obtained with both chemical and genetic
inhibition of PHDs strongly suggest that PHD activity is required
Figure 3. Inhibition of PHD by DMOG induces autophagy independently of HIF. U2OS cells stably expressing GFP-LC3 were transfected with a
plasmid encoding control, nontargeting shRNA (shCntr) or transfected with a plasmid encoding shRNA for HIF1b (clone no. 4; shHIF1b no. 4).
After 48 h, cells were incubated for 5 h in the presence of amino acids with or without DMOG as indicated. Aggregation of GFP-LC3 was
analyzed by fluorescence microscopy (a) and quantified (b). Results represent the average and s.d. of three independent experiments.
Figure 4. Reduction of intracellular aKG during amino-acid starvation correlates with mTORC1 inhibition. (a, b) Intracellular aKG levels (a) and
phosphorylation status of S6K and S6 proteins (b) in U2OS cells at different time points after incubation without amino acids. (c, d)
Intracellular aKG levels (c) and phosphorylation status of S6K and S6 proteins (d) in U2OS cells under normal (non-starved) conditions, under
starvation for amino acids for 3 h (AA) or under starvation for amino acid for 2 h followed by re-addition of amino acids for 1 h (þAA).
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for mTORC1 activation by amino acids. These results also propose
a partial redundancy between all three PHDs in their response to
amino acids and in mediating mTORC1 activation.
PHDs signal to mTORC1 via the Rag GTPases
As we demonstrated that HIF was not affected by PHD inhibition
during amino-acid starvation, we hypothesized that mTORC1
downregulation during PHD inhibition is independent of HIF,
which can inhibit mTORC1 via the activation of the TSC1/2
complex.22 To test this possibility HIF activity was efﬁciently
silenced, as judged by the lack of REDD1 induction by DMOG in
the presence of amino acids (Figure 6a) and as expected, HIF
silencing did not prevent the inhibition of mTORC1 by DMOG
(Figure 6a). Therefore, we concluded that PHDs are required to
maintain mTORC1 in a HIF-independent manner. Furthermore,
DMOG treatment prevented mTORC1 activation by amino acids in
both TSC2þ /þ and TSC2 / mouse embryonic ﬁbroblasts
(Figure 6b). In contrast, the expression of a constitutively active
mutant of Rheb, which activates mTORC1 even in the absence of
amino acids,23 also induced S6K and S6 phosphorylation in the
presence of DMOG (Figure 6c). These results suggest that PHDs
signal toward mTORC1 through the amino-acid-signaling path-
way, which involves the Rag small GTPases,24 and not through the
TSC1/2 pathway. Indeed, the expression of a constitutively active
Rag also rescued mTORC1 activation in starved cells both in the
presence or absence of DMOG (Figure 6d). Altogether, this work
suggests that aKG-dependent activity of PHDs is necessary for
mTORC1 activation by amino acids through the Rag GTPases and
in a HIF/TSC-independent manner.
DISCUSSION
We demonstrate here that the ability of amino acids to induce
mTORC1 signaling strictly requires PHD enzymatic activity. We
show that aKG is an intracellular indicator of amino-acid
Figure 5. Inhibition of PHDs blocks the response of mTORC1 to
amino acids. (a, b) Phosphorylation state of S6K, S6 and 4EBP1 in
cells starved for 2 h and then re-fed with amino acids for one more
hour in the presence or absence of DMOG, rapamycin (Rap) or
cobalt chloride (CC). (c) U2OS cells were transfected with a plasmid
encoding control, nontargeting shRNA (shCntr) or cotransfected
with three different plasmids encoding shRNAs for each member of
the PHD family (shPHDs). After 48 h, cells were starved for amino
acids for 2 h and then incubated for 20min with (þ AA) or without
( AA) amino acids. The phosphorylation state of S6 was analyzed
by western blot. (d) Cells were transfected as in (c) and starved for
amino acids for 2 h and then incubated for the indicated time with
amino acids (þ AA). The phosphorylation state of S6K was analyzed
by western blot.
Figure 6. PHDs signal to mTORC1 in a HIF/TSC-independent manner.
(a) U2OS cells were transfected with a plasmid encoding control,
nontargeting shRNA (shCntr) or transfected with a plasmid
encoding shRNA for HIF1b (clone no. 4; shHIF1b no. 4). After 48 h,
cells were starved for amino acids for 2 h and then incubated for
20min with (þ AA) or without ( AA) amino acids either in the
presence or absence of DMOG. Accumulation of REDD1 and
phosphorylation state of S6K and 4EBP1 were analyzed by western
blot. (b) Phosphorylation status of S6K in TSC2þ /þ and TSC2 /
mouse embryonic fibroblasts starved for 2 h and then re-fed with
amino acids for one more hour in the presence or absence of
DMOG. (c) U2OS cells were transfected with either empty vector or
Flag-Rheb-GTP, as indicated. After 48 h, cells were amino-acid
starved for 2 h and re-stimulated for 1 h with amino acids (AA)
either in the presence or absence of DMOG, as indicated.
Phosphorylation of S6K and S6 was then measured by immunoblot-
ting. (d) U2OS cells were transfected with either empty vector or
with HA-RagB-GTP plus HA-RagC-GDP, as indicated. After 48 h, cells
were amino-acid starved for 1 h where indicated, DMOG was added
30min before the collection of the cells. Phosphorylation of S6K and
S6 was then measured by immunoblotting.
Figure 7. Model for oxygen- and nutrient-sensing mechanisms by
PHDs. Left side: PHDs mediate the inhibition of HIF in the presence
of oxygen. Under hypoxia, lack of oxygen inhibits PHD activity,
resulting in the stabilization of HIF, which inhibits mTORC1 via
REDD1 induction. Right side: PHDs are required for the activation of
mTORC1 in the presence of amino acids. Under amino-acid
starvation, lack of aKG inhibits PHD activity, resulting in the
inhibition of mTORC1, hence a reduction in HIF expression. Loss
of PHD activity can also mediate the induction of autophagy under
amino-acid starvation conditions in a HIF-independent manner.
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availability, and it transduces the information to PHDs, which in
turn, are required for mTORC1 pathway activation. Importantly, in
a recent report we also demonstrated that aKG production
through glutaminolysis is a necessary step for the activation of
mTORC1 by leucine and glutamine.25 The results in this study
conﬁrm and extend this previous report. Of note, the estimated
in vitro KM of PHDs for aKG is B50 mM,
26 while we previously
calculated an intracellular aKG concentration in steady state in the
range of 100mM,27 indicating that PHDs are good candidates to
sense aKG oscillations. In this model, PHD enzymes do not
function solely as intracellular oxygen sensors, but also as nutrient
sensors (Figure 7). As the effect of amino acids on mTORC1 was
severely hindered by DMOG or PHDs silencing, it appears that
PHD activity is necessary for a complete mTORC1 response to
amino acids. Interestingly, PHD1 regulates energy metabolism in
muscle28 in a similar manner to mTORC1.29 Furthermore, like
dTOR, the Drosophila homolog of mTOR,30 the Drosophila PHD is
also required for cell growth.31 These observations genetically
position PHDs and mTORC1 in a similar metabolic axis and
together with our new data they propose a biological role of PHDs
in turning nutrient availability or scarcity to signals that control cell
growth or autophagy.
HIFa is the most-studied substrate of PHD enzymes, yet we have
shown that HIF is not involved in the amino-acid-sensing process.
The direct substrates of PHDs in the amino-acid-sensing pathway
are yet to be identiﬁed. Nevertheless, the observation that PHDs
clearly respond to amino acids indicates that these enzymes have
important roles in metabolic control. The involvement of PHDs in
the oxygen- and amino-acid-sensing mechanisms designates
them as major cellular metabolic sensors. This dual role for PHDs
raises the question how cells distinguish between oxygen- and
amino-acid-limiting conditions. In fact, inhibition of PHDs under
hypoxia leads to the accumulation of HIF1, which inhibits mTORC1
through REDD1 induction.32 On the other hand, PHD inhibition by
amino-acid starvation leads to reduced mTORC1 activity, which
prevents HIF1a translation.33 This feedback loop prevents HIF
activation under amino-acid starvation, despite the fact that PHDs
are inactivated.
In conclusion, we propose that PHD proteins function as general
metabolic sensors in the cell, signaling scarcity not only of oxygen
but also of amino acids and forming a link between amino-acid
availability and the mTORC1 pathway.
MATERIALS AND METHODS
Reagents
Reagents were obtained from the following sources: Antibodies against
ribosomal S6, phospho-S235/236 S6, S6K1, phospho-T389 S6K1, 4EBP1,
AMP-activated protein kinase, phospho-T172 AMP-activated protein
kinase, IkB kinase b, phospho-S180/S181 IkB kinase a/b, IkBa and
phospho-S32/36 IkBa were obtained from Cell Signalling Technology,
Beverly, MA, USA; anti-GFP and anti-HIF1a were obtained from BD
Biosciences, Franklin Lakes, NJ, USA; anti-actin, anti-tubulin and anti-BNIP3
were obtained from Sigma (Gillingham, UK); antibody against REDD1 was
obtained from the ProteinTech Group, Chicago, IL, USA; anti-Glut1 was
obtained from Abcam, Cambridge, UK; antibody against PHD1 was
obtained from Novus, Littleton, CO, USA; PHD2 and PHD3 antibodies were
kindly provided by Kevin Gatter; all horseradish peroxidase-conjugated
secondary antibodies were from Cell Signalling Technology; every
antibody was used at the manufacturer’s recommended dilution. TaKG
was obtained as described previously.12 6-Diazo-5-oxo-l-norleucine, CoCl2,
DMOG and rapamycin were from Sigma.
Plasmids, shRNAs and transfections
The plasmid pGL2/hypoxia responsive element (HRE)-luciferase was described
elsewhere.10 pFLAG-PHD2 was obtained from Origene, Rockville, MD, USA.
For knockdown experiments, pLKO.1-derived plasmids containing shRNA
for PHD1 (RHS3979-9589735), PHD2 (RHS3979-9569473), PHD3 (RHS3979-
9569477) and HIF1b/ARNT (RHS4533-NM_178427) were purchased from
Open Biosystems, Lafayette, CO, USA. pLKO.1 plasmid containing control
shRNA (Addgene plasmid 1864, Cambridge, MA, USA), plasmid expressing
HA-RagB-Q99L (RagB-GTP; Addgene plasmid 19303) and plasmid expressing
HA-RagC-S75L (RagC-GDP; Addgene plasmid 19305) were kindly provided
by David M Sabatini.34 Plasmid expressing FLAG-Rheb-N153T (RhebGTP;
Addgene plasmid 19997) was kindly provided by Fuyuhiko Tamanoi.
Cells were transfected with lipofectamine (Invitrogen, Carlsbad, CA, USA)
following the manufacturer’s instructions.
Cell culture
U2OS, HeLa and mouse embryonic ﬁbroblasts (both TSC2þ /þ and
TSC2 / ) were cultured in Dulbecco’s modiﬁed Eagle’s medium
supplemented with 10% fetal calf serum and 2mM L-glutamine. HCT116
cells stably expressing GFP-ODD (CL18 cells) were described previously.27
CL18 cells were cultured in RPMI medium supplemented with 10% fetal
calf serum and 2mM L-glutamine. For amino-acid starvation, cells were
incubated in Krebs-Ringer Bicarbonate Buffer (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid 25mM, NaCl 111mM, NaHCO3 25mM, KCl
5mM, CaCl2 2.5mM and MgCl2 1mM) supplemented with glucose (4.5 g/l).
Standard starvation time was 2 h, unless otherwise indicated. When
required, cells were re-fed with a solution with all essential and
nonessential amino acids (Invitrogen) during the indicated time. For
TaKG re-stimulation purposes, these compounds were added to a ﬁnal
concentration of 1mM for the indicated time. Inhibitors such as DMOG
(1mM ﬁnal concentration), CoCl2 (0.5mM ﬁnal concentration), 6-diazo-5-
oxo-l-norleucine (40mM ﬁnal concentration) or rapamycin (50 nM ﬁnal
concentration) were added 1 h before the re-stimulation with amino acids.
Hypoxia was achieved using a humidiﬁed, Invivo2 500 hypoxic chamber
(Biotrace, Bridgend, UK) and Ruskin hypoxic gas mixer at 37 1C with 1% O2,
5% CO2 and 94% N2. For U2OS cells stably expressing the NF-kB-luciferase
reporter, U2OS cells were transfected with the 2 mg of NF-kB-reporter
construct pGL4.32[luc2P/NF-kB-RE/Hygro] (Promega, Madison, WI, USA)
using genejuice (Merck Biosciences, Darmstadt, Germany). After 48 h,
cells were split and cultivated under 300mg/ml Hygromycin B (Roche,
Indianapolis, IN, USA). Individual clones were picked and selected based
on their response to tumor necrosis factor-a.
Protein analysis
For western blot analysis, cells were extracted in Laemmli sample buffer.
Following sodium dodecyl sulfate–polyacrylamide gel electrophoresis,
proteins were blotted onto nitrocellulose and analyzed with the
appropriate antibody, using the ECL kit (GE Healthcare, Piscataway, NJ,
USA) for detection.
Measurement of a-ketoglutarate
Intracellular levels of alpha-ketoglutarate were determined by following
the method described previously.12 U2OS cells were washed with
phosphate-buffered saline and lysed with RIPA buffer (50mM Tris–HCl
(pH 7.4), 150mM NaCl, 1% Triton X 100, 1% sodium deoxycholate, 0.1%
sodium dodecyl sulfate supplemented with protease inhibitor cocktail
(Invitrogen)). Cell lysates were collected from the plate, vortexed
vigorously and centrifuged for 5min at 15 000 g at 4 1C. Aliquots of
the extracts were analyzed immediately for alpha-ketoglutarate. The assay
solution consisted of 100mM KH2PO4 (pH 7.2), 10mM NH4Cl, 5mM MgCl2
and 0.15mM nicotinamide adenine dinucleotide (Roche). Following
equilibration at 37 1C with extract, the reaction was started by the
addition of 5 units of glutamate dehydrogenase (Sigma). The
absorbance decrease was monitored at 340 nm. The intracellular level of
a-ketoglutarate was determined from the absorbance decrease in
nicotinamide adenine dinucleotide (extinction coefﬁcient, 6.22/mM/cm).
Measurement of oxygen consumption rate
A total of 3 104 cells were plated onto XF24 plates (Seahorse Bioscience,
North Billerica, MA, USA) and incubated at 37 1C, 5% CO2 for 24 h. The
medium was then replaced with 675ml of unbuffered Dulbecco’s modiﬁed
Eagle’s medium (Seahorse Bioscience) supplemented with 2mmol
glutamine, 25mmol glucose and 2% fetal bovine serum (pH was adjusted
to 7.4 using sodium hydroxide 0.5 M) and cells were incubated at 37 1C in a
CO2-free incubator. Basal oxygen consumption rate was then recorded
using the XF24 plate reader (Seahorse Bioscience). Every cycle of
measurement consisted of 3min mix, 3min wait and 4min measure.
Oxygen consumption rate was normalized to cell number calculated
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at the end of the experiments. Homogeneous plating of the cells and
cell count was obtained by ﬁxing the cells with trichloroacetic acid 10% for
1 h at 4 1C and then staining the ﬁxes cells with 0.47% solution of
Sulforhodamine B (Sigma).
Measurement of intracellular ATP levels
A total of 2 105 cells were grown on six well plates and treated as
indicated. ATP was measured from the cell lysates of the same samples
using a luciferase-based assay as per manufacturer’s instructions (Sigma).
Data were normalized to total protein contents of the cell lysate
determined by Bicinchoninic Acid Assay (Thermoscientiﬁc, Rockford, IL,
USA) using bovine serum albumin as standard.
Luciferase assay
For HRE-luciferase assays, U2OS cells were transfected with either wild type
or mutant pGL2/HRE-luciferase 48 h before start of the experiment.
Luciferase intensity was determined using the Luciferase Assay System
(Promega) by following manufacturer’s instruction and using a VeritasMi-
croplateLuminometer (Turner Biosystems, Madison, WI, USA). For NF-kB-
luciferase assay, cells were processed as described previously35 using the
Luciferase Assay System (Promega).
Measurement of intracellular content of amino acids
U2OS cells were plated in six wells plates (8 105 cells per well). After 24 h,
cells were rapidly washed with phosphate-buffered saline and incubated
for the indicated times in Krebs-Ringer Bicarbonate Buffer supplemented
with glucose, essential and nonessential amino acids (Invitrogen), in the
presence or absence of 2mM glutamine. At the end of the treatments, the
intracellular content of amino acids was determined as described
previously.36 Brieﬂy, cells were washed twice with ice cold phosphate-
buffered saline, extracted for 5min on ice with 1ml of a 6.6-mM acetic acid
solution in ethanol,and analyzed with a Biochrom 20 Amino Acid Analyzer
(Biochrom, Cambridge, UK) using a High-Resolution Column Bio 20
Peek Lithium and the Physiological Fluid Chemical Kit (Biochrom) for
elution. The column efﬂuent was mixed with ninhydrin reagent, passed
through the high temperature reaction coil and read by the photometer
unit. Data are normalized on a standard curve and expressed as nmol/mg
of protein.
Autophagy measurements
U2OS cells stably expressing LC3-GFP where cultured in Iwaki glass-
bottomed dishes. After 5 h, treatment in starving conditions either in the
presence or absence of DMOG, GFP localization was detected using a
confocal microscopy using a SP2 DMIRBE laser scanning confocal
microscope with SP2 software (Leica, Wetzlar, Germany). GFP aggregation
was then quantiﬁed.
GFP-ODD quantiﬁcation
Fluorescence in HCT116 cell line stably expressing a GFP–ODD fusion
protein was analyzed directly in culture using an Olympus CX41
Fluorescent Tissue Culture Microscope (Olympus, Tokyo, Japan).
Statistical analyses
Data were expressed as average±s.d. of at least three independent
experiments. Student’s t-test was used to determine differences among
two groups. Signiﬁcance was judged when Po0.05.
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